Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases
Background. Inefficacy of conventional chronic spontaneous urticaria (CSU) treatments significantly reduces patients’ quality of life. Data on CSU (triggered by new coronavirus infection) prevalence and course in children is very limited.Clinical case description. Authors have presented three clinic...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2024-12-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/2550 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849243795919470592 |
|---|---|
| author | Aset Kh. Ibisheva Madina R. Shakhgireeva Linda V.-M. Dzhabrailova Asya B. Khildikharoeva Linda S. Uspanova Kamila A.-R. Getaeva |
| author_facet | Aset Kh. Ibisheva Madina R. Shakhgireeva Linda V.-M. Dzhabrailova Asya B. Khildikharoeva Linda S. Uspanova Kamila A.-R. Getaeva |
| author_sort | Aset Kh. Ibisheva |
| collection | DOAJ |
| description | Background. Inefficacy of conventional chronic spontaneous urticaria (CSU) treatments significantly reduces patients’ quality of life. Data on CSU (triggered by new coronavirus infection) prevalence and course in children is very limited.Clinical case description. Authors have presented three clinical cases of CSU onset after the new coronavirus infection. Clinical features of disease and targeted therapy efficacy were evaluated.Conclusion. The course of CSU, potentially triggered by SARS-CoV-2, has its own features, and requires larger research with the study of clinical and laboratory aspects, as well as the immunological mechanisms underlying the disease, with revealing biomarkers indicating disease severity, course, and prognosis. |
| format | Article |
| id | doaj-art-fe68554d95f844fcb46dffa4e76cae3e |
| institution | Kabale University |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2024-12-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-fe68554d95f844fcb46dffa4e76cae3e2025-08-20T03:59:21ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892024-12-0121649650210.15690/pf.v21i5.27982138Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical CasesAset Kh. Ibisheva0Madina R. Shakhgireeva1Linda V.-M. Dzhabrailova2Asya B. Khildikharoeva3Linda S. Uspanova4Kamila A.-R. Getaeva5Republican Children’s Clinical Hospital named after E.P. GlinkaRepublican Children’s Clinical Hospital named after E.P. GlinkaRepublican Children’s Clinical Hospital named after E.P. GlinkaRepublican Children’s Clinical Hospital named after E.P. GlinkaRepublican Children’s Clinical Hospital named after E.P. GlinkaRepublican Children’s Clinical Hospital named after E.P. GlinkaBackground. Inefficacy of conventional chronic spontaneous urticaria (CSU) treatments significantly reduces patients’ quality of life. Data on CSU (triggered by new coronavirus infection) prevalence and course in children is very limited.Clinical case description. Authors have presented three clinical cases of CSU onset after the new coronavirus infection. Clinical features of disease and targeted therapy efficacy were evaluated.Conclusion. The course of CSU, potentially triggered by SARS-CoV-2, has its own features, and requires larger research with the study of clinical and laboratory aspects, as well as the immunological mechanisms underlying the disease, with revealing biomarkers indicating disease severity, course, and prognosis.https://www.pedpharma.ru/jour/article/view/2550chronic spontaneous urticariasars-cov-2childrenomalizumab |
| spellingShingle | Aset Kh. Ibisheva Madina R. Shakhgireeva Linda V.-M. Dzhabrailova Asya B. Khildikharoeva Linda S. Uspanova Kamila A.-R. Getaeva Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases Педиатрическая фармакология chronic spontaneous urticaria sars-cov-2 children omalizumab |
| title | Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases |
| title_full | Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases |
| title_fullStr | Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases |
| title_full_unstemmed | Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases |
| title_short | Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases |
| title_sort | chronic spontaneous urticaria after new coronavirus infection clinical cases |
| topic | chronic spontaneous urticaria sars-cov-2 children omalizumab |
| url | https://www.pedpharma.ru/jour/article/view/2550 |
| work_keys_str_mv | AT asetkhibisheva chronicspontaneousurticariaafternewcoronavirusinfectionclinicalcases AT madinarshakhgireeva chronicspontaneousurticariaafternewcoronavirusinfectionclinicalcases AT lindavmdzhabrailova chronicspontaneousurticariaafternewcoronavirusinfectionclinicalcases AT asyabkhildikharoeva chronicspontaneousurticariaafternewcoronavirusinfectionclinicalcases AT lindasuspanova chronicspontaneousurticariaafternewcoronavirusinfectionclinicalcases AT kamilaargetaeva chronicspontaneousurticariaafternewcoronavirusinfectionclinicalcases |